Does Omega-3 Actually Slow Aging?

Brain & Aging 2026

Does Omega-3 Actually Slow Aging?

A 2025 trial found 1 g of omega-3 a day slightly slowed biological-aging 'clocks' — about 3 to 4 months over 3 years. Here's what that really means.

By Jaden Choi — a plain-English look at what the omega-3 and "biological age" research actually found, and where the headlines get ahead of the data.

Sort of — but the honest answer is "a little, maybe, by one specific measure." In 2025, a well-run analysis from the DO-HEALTH trial found that taking 1 gram of omega-3 a day slightly slowed several "biological-aging clocks" in adults over 70 — on the order of a few months over three years. That's a genuine, peer-reviewed signal, and it's interesting. It is also small, measured by a surrogate biomarker rather than by how long or how well people actually lived, and it comes from the same trial whose main health results were underwhelming.

So this is a story with a real finding and a big asterisk. Below, we'll unpack what a "biological-aging clock" even is, exactly what the 2025 study did and found, how large the effect really was, why the broader trial complicates the headline, and what the research does — and doesn't — let you conclude about fish oil and aging. None of this is medical advice for your situation; it's what the published science shows.

📌 Key Takeaways
  • A 2025 analysis in Nature Aging from the DO-HEALTH trial found 1 g/day of omega-3 slowed several DNA-methylation "aging clocks" (PhenoAge, GrimAge2, and the pace measure DunedinPACE) in adults over 70.
  • The effect was small — roughly 0.16–0.32 units, about 2.9 to 3.8 months of slowed biological aging across three years. Combining omega-3, vitamin D, and exercise added a bit more on one clock.
  • Big caveat: the parent DO-HEALTH trial (JAMA, 2020) found no significant benefit of these same interventions on its main clinical outcomes. The aging-clock result was a post hoc, exploratory add-on.
  • Aging clocks are surrogate biomarkers, not proof of a longer, healthier life. "Slower on a clock" is a promising hint, not a demonstrated anti-aging effect — talk to your doctor before changing anything.

First: What Is a "Biological-Aging Clock"?

Your chronological age is just how many birthdays you've had. Your biological age is a fuzzier idea: how worn or resilient your body actually is, which can run ahead of or behind the calendar. The question researchers have chased for a decade is whether you can measure biological age objectively — and then whether anything you do can nudge it.

The current best tools are epigenetic clocks. They don't read your DNA sequence; they read DNA methylation — tiny chemical tags that sit on top of your genes and change in patterned ways as you age. By measuring methylation at hundreds of specific sites and running it through a formula trained on large populations, a clock spits out an estimate of your biological age or your rate of aging.

Several generations of these clocks exist, and the 2025 study used four of the more advanced ones:

  • PhenoAge and GrimAge / GrimAge2 — "second-generation" clocks trained not just on age but on clinical markers and mortality risk, so they aim to track health, not just years.
  • DunedinPACE — a different animal: instead of estimating an age, it estimates your pace of aging (think "years of biological aging per calendar year").

These clocks are among the most striking tools in aging science — but, as we'll see, a slower clock reading is a biomarker, not a guarantee of extra healthy years. Hold on to that distinction; it's the whole ballgame.

The 2025 Study That Made the Headlines

The finding comes from the DO-HEALTH trial, a large European study, and specifically from a 2025 analysis published in Nature Aging (led by Heike Bischoff-Ferrari and colleagues). Here's the setup, because the design is unusually clean:

  • Who: This clock analysis drew on 777 participants from the broader 2,157-person trial — generally healthy adults aged 70 and older (median around 74) living across five European countries.
  • What they tested: a 2×2×2 factorial design, meaning each person was randomly assigned a yes/no on three things at once: vitamin D3 (2,000 IU/day), marine omega-3 (1 g/day), and a home strength-exercise program.
  • For how long: three years, with the four DNA-methylation clocks measured over that span.

Because it's a randomized, placebo-controlled trial rather than a survey, it can speak to cause, not just correlation — a real strength. Here's what it found:

  • Omega-3 alone slowed three of the four clocks — PhenoAge, GrimAge2, and DunedinPACE. It was the standout single intervention.
  • All three together (omega-3 + vitamin D + exercise) produced an additive benefit on PhenoAge — the combination did a bit better than any one piece on that particular clock.
  • Vitamin D alone and exercise alone had weaker or inconsistent effects on their own in this analysis, with the clearest individual signal coming from omega-3.

That's a legitimately novel result: a cheap, common supplement, in a randomized trial, moving validated aging biomarkers in the "younger" direction. No wonder it got written up as "omega-3 slows aging." The problem is only that the write-ups usually stop there.

How Big Was the Effect, Really?

This is where enthusiasm needs to meet arithmetic. The authors themselves describe the effect as small. Across the clocks, the intervention effects landed around 0.16 to 0.32 units, which the researchers translate to roughly 2.9 to 3.8 months of slowed biological aging — the source of the "almost four months" figure in the press.

Read that carefully: that's a few months of difference on a biomarker, accumulated over three full years of daily supplementation. It is not "take fish oil and knock years off your age." It's a nudge — directionally encouraging, modest in size, and (crucially) measured on a lab reading rather than on anything you'd feel or that a doctor would chart.

💡 The one-sentence version

A randomized trial found daily omega-3 slowed several aging-clock readings by about three to four months over three years in people over 70 — a real but small signal on a biomarker, not a proven fountain of youth.

The Catch: The Main Trial Didn't Improve Health Outcomes

Here's the context almost no headline mentions. The aging-clock paper was a post hoc, exploratory analysis — a follow-up question asked of data already collected, not the trial's pre-registered main goal. And the trial's actual main results, published in JAMA in 2020, were a letdown.

Across its primary clinical endpoints — a composite that included blood pressure, cognition, risk of nonvertebral fractures, functional decline, and infection rates — DO-HEALTH found no statistically significant benefit from vitamin D, omega-3, or the exercise program over three years. The interventions did not meaningfully move the health outcomes the researchers had set out to improve.

Later secondary analyses did surface some intriguing signals: one 2022 report suggested the combination of all three appeared to cumulatively lower the risk of invasive cancer, and other analyses hinted at reduced pre-frailty. But those are secondary findings from the same deeply sliced dataset, and other outcomes (major cardiovascular events, muscle mass) showed no benefit. So the full picture is a trial that largely missed on hard clinical outcomes, with a scattering of promising-but-unconfirmed secondary hits — the aging clocks among them.

This matters for honesty. When a study's main pre-planned outcomes come up empty, the exploratory findings that follow are hypothesis-generating — worth noticing, worth testing further, but not yet the kind of result you'd bet your routine on. The omega-3 clock effect is exactly that: a good lead, not a verdict.

What Aging Clocks Can — and Can't — Tell You

Even setting the trial aside, there's a deeper limit worth understanding: a slower epigenetic clock is a surrogate marker, not an outcome.

Aging clocks are impressive at predicting things like mortality and disease risk across large groups. But "an intervention shifts a clock" is not the same as "the intervention makes people live longer or healthier." The clock is a proxy. Researchers in the field, including the authors here, are careful to note that we can't yet draw a clean cause-and-effect chain from "this moved the methylation pattern" to "this added healthy years." It's entirely possible for something to tweak a biomarker without delivering the real-world benefit the biomarker usually tracks — medicine is littered with surrogate markers that looked great and didn't pan out.

A few specific caveats to keep in mind about this result:

  • It's a surrogate endpoint. The study measured clocks, not lifespan or healthspan. Slower clock ≠ proven longer healthy life.
  • The population is specific. These were generally healthy adults over 70 in Europe. Whether the same holds for a 40-year-old is unknown.
  • It was exploratory. Post hoc analyses that look across several clocks raise the chance of finding something by chance; replication in a trial designed for this question is the real test.
  • The effect is small. A few months on a biomarker over three years is not a dramatic rejuvenation.

The Signal vs. the Proof — An Honest Scorecard

Question What the research shows
Did omega-3 move an aging biomarker? Yes — a 2025 randomized analysis slowed PhenoAge, GrimAge2, and DunedinPACE.
By how much? Small — about 2.9–3.8 months of slowed biological aging over 3 years.
Was it the trial's main finding? No — post hoc/exploratory. The trial's primary clinical endpoints were null (JAMA, 2020).
Does it prove a longer, healthier life? No — clocks are surrogate markers, not demonstrated outcomes.
Who was studied? Generally healthy European adults aged 70+; findings may not generalize to younger people.

So Should You Take Omega-3 to Slow Aging?

That's a decision for you and your doctor, not a blog — but the research supports a few reasonable framings:

  1. Don't expect a miracle from the clock result. If "reverse your biological age" is the pitch, the actual data behind it is a small, exploratory, biomarker-level effect in older adults. Calibrate accordingly.
  2. Omega-3 has other, better-established reasons to be on the radar. Diets rich in the marine omega-3s EPA and DHA — from fatty fish like salmon and sardines — are broadly recommended for general health, and major health agencies treat seafood as part of a heart-healthy pattern. "Food first" is the least controversial route.
  3. Supplements aren't risk-free or right for everyone. Omega-3 can interact with blood thinners and isn't automatically beneficial for everyone; high-dose fish oil has its own research debates. Dose and need depend on your health, diet, and medications.
  4. Let a clinician individualize it. Whether a supplement makes sense for you — and at what dose — is a medical question. This finding is a reason to ask, not a reason to self-prescribe.

The grounded takeaway: the 2025 study is a legitimately interesting hint that omega-3 might touch the biology of aging, not a license to treat fish oil as an anti-aging drug. Good science often looks like this — a promising signal that now needs a trial built specifically to confirm it.

Frequently Asked Questions

Does omega-3 really slow down aging?

By one measure, a little. A 2025 analysis from the DO-HEALTH trial, published in Nature Aging, found that 1 gram of omega-3 a day slowed several DNA-methylation "aging clocks" in adults over 70 — by roughly 3 to 4 months over three years. That's a real, randomized finding, but it's small, it was an exploratory analysis, and it was measured on a biomarker rather than on actual lifespan or health outcomes. It's a promising hint, not proof that fish oil makes you age more slowly in a way you'd feel.

How much omega-3 did the study use?

One gram (1,000 mg) of marine omega-3 per day, taken for three years, in people aged 70 and older. The trial also tested 2,000 IU/day of vitamin D and a home strength-exercise program; combining all three added a small extra benefit on one of the aging clocks (PhenoAge), but omega-3 was the clearest single contributor. This is a description of what the study did, not a dosing recommendation for you — talk to your doctor about what's appropriate.

What's a "biological age" or "epigenetic clock"?

It's an estimate of how old your body seems biologically, calculated from DNA-methylation patterns — chemical tags on your genes that shift with age. Clocks like PhenoAge and GrimAge estimate a biological age, while DunedinPACE estimates your rate of aging. They're good at predicting health risks across groups, but a change in a clock is a surrogate marker: it doesn't automatically prove that someone will live longer or healthier.

If the clocks improved, why was the main trial called a disappointment?

Because the aging-clock result wasn't the trial's main goal. DO-HEALTH's pre-planned primary outcomes — published in JAMA in 2020 and covering things like blood pressure, cognition, fractures, and infections — showed no significant benefit from the interventions. The aging-clock finding came from a later, exploratory analysis. Exploratory findings are worth following up, but they carry less weight than the outcomes a trial was actually designed to test.

Bottom Line — What the Research Actually Supports

So does omega-3 slow aging? The careful, honest answer:

  1. There's a real, randomized signal: a 2025 Nature Aging analysis found 1 g/day of omega-3 slowed several biological-aging clocks in adults over 70.
  2. But it's small: roughly 3 to 4 months of slowed clock-aging over three years — a biomarker nudge, not a dramatic rejuvenation.
  3. And it's unconfirmed: it was an exploratory analysis from a trial whose main clinical outcomes were null, so it's a lead that needs a dedicated trial to verify.
  4. Clocks aren't outcomes: moving a surrogate marker isn't the same as proven extra healthy years.

Treat this as a reason to be curious about omega-3, not a reason to expect your birthdays to slow down. If you're weighing fish oil for healthy aging — especially if you're older, take blood thinners or other medications, or manage a health condition — bring this study to your doctor and decide together. That's where a promising research signal belongs: in a conversation about your actual health, not in a supplement-shelf promise.


Sources

  • Bischoff-Ferrari HA, et al. "Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial." Nature Aging, 2025 (published online Feb 3, 2025) — post hoc analysis of 777 DO-HEALTH participants aged 70+; 1 g/day marine omega-3 slowed the PhenoAge, GrimAge2, and DunedinPACE clocks, with an additive effect of all three interventions on PhenoAge; effects described as small (~0.16–0.32 units, ~2.9–3.8 months over 3 years). DOI: 10.1038/s43587-024-00793-y · PMID 39900648
  • Bischoff-Ferrari HA, et al. "Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial." JAMA, 2020;324(18):1855–1868 — the parent trial (2,157 adults aged ≥70 across five European countries, 2×2×2 factorial, 3 years) found no significant benefit of the interventions on its primary clinical endpoints. DOI: 10.1001/jama.2020.16909
  • Bischoff-Ferrari HA, et al. "Combined Vitamin D, Omega-3 Fatty Acids, and a Simple Home Exercise Program May Reduce Cancer Risk Among Active Adults Aged 70 and Older: A Randomized Clinical Trial." Frontiers in Aging, 2022;3:852643 — a secondary analysis reporting that the combination appeared to cumulatively lower the risk of invasive cancer (a secondary, not primary, outcome). DOI: 10.3389/fragi.2022.852643
  • National Institutes of Health, Office of Dietary Supplements. "Omega-3 Fatty Acids — Fact Sheet for Health Professionals." — background on EPA/DHA, dietary sources, typical intakes, and safety considerations. ods.od.nih.gov

This article summarizes published research for general educational purposes and is not medical advice. It does not diagnose, treat, or recommend any specific supplement, dose, or regimen for any individual, and biological-aging "clocks" are research biomarkers, not validated measures of how long or how well you will live. Omega-3 supplements can interact with medications (including blood thinners) and are not appropriate for everyone. Research evolves and findings can be revised. Talk to your doctor or a licensed healthcare provider before starting, stopping, or changing any supplement — especially if you are older, pregnant, taking medication, or managing a health condition. Information is current as of November 2026.